| Date Filed | Type | Description |
| 08/11/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 06/05/2023 |
4
| Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 27,775,050 shares
@ $2.6, valued at
$72.2M
|
|
| 05/12/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/11/2023 |
4
| Westend S.A. (10% Owner) has filed a Form 4 on WW INTERNATIONAL, INC.|
Txns:
| Sold 14,818,300 shares
@ $7.15, valued at
$106M
|
|
| 05/02/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Bought 31,557 shares
@ $6.4279, valued at
$202.8k
|
|
| 02/28/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Bought 100,000 shares
@ $1.7, valued at
$170k
|
|
| 02/23/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Bought 50,000 shares
@ $1.85, valued at
$92.5k
Bought 150,000 shares
@ $1.7933, valued at
$269k
Bought 200,000 shares
@ $1.7538, valued at
$350.8k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/13/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 01/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2022 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Bought 33,971 shares
@ $7.0292, valued at
$238.8k
Bought 66,000 shares
@ $7.8903, valued at
$520.8k
|
|
| 08/11/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2022 |
4
| Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 16,173,800 shares
@ $2.5, valued at
$40.4M
|
|
| 06/24/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/12/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/11/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/11/2022 |
SC 13G/A
| Artal International Management S.A. reports a 4.1% stake in RUBIUS THERAPEUTICS, INC. |
| 11/12/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/13/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/03/2021 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Bought 75,000 shares
@ $16.1379, valued at
$1.2M
Converted 1,323,530 shares
@ $0
Bought 875,000 shares
@ $17, valued at
$14.9M
Converted 5,000,000 convertible preferred
@ $0 |
|
| 07/29/2021 |
3
| Invus Public Equities, L.P. (10% Owner) has filed a Form 3 on Omega Therapeutics, Inc. |
| 05/14/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 03/08/2021 |
SC 13G
| Artal International Management S.A. reports a 5.5% stake in RUBIUS THERAPEUTICS, INC. |
| 02/11/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 10,937,500 shares
@ $3.2, valued at
$35M
|
|
| 12/10/2020 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on Seer, Inc.|
Txns:
| Converted 5,050,911 shares
@ $0
Bought 790,000 shares
@ $19, valued at
$15M
Converted 3,953,381 convertible preferred
@ $0
Converted 373,831 convertible preferred
@ $0
Converted 474,478 convertible preferred
@ $0
Converted 249,221 convertible preferred
@ $0 |
|
| 12/03/2020 |
3
| Invus Public Equities, L.P. (10% Owner) has filed a Form 3 on Seer, Inc. |
| 11/13/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
|